A certified one-hour program for medical imaging and healthcare professionals including: radiologists, interventional radiologists, oncologists, and surgeons with a focus on challenging cases.
In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women.1 Early detection and treatment can often mean the difference between life and death.
Based on recent evidence on the efficacy of breast magnetic resonance imaging (MRI) screening in high-risk patients, the American Cancer Society (ACS) has issued guidelines for the early detection of breast cancer that include MRI.2 Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for preoperative planning.
This series brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their practice.
1 Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics. Available at http://seer.cancer.gov
2 Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
Educational Objectives for the Series
At the conclusion of this activity, participants should be better able to:
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Participate
There are no fees to participate in this activity. Each participant will need a computer with internet access.
Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.
After completing his undergraduate degree in anthropology at the University of Washington, Dr. Eby received his medical degree from Vanderbilt University. He completed his residency in diagnostic radiology and fellowships in emergency radiology and breast imaging at the University of Washington.
Until earlier this year, Dr. Eby served as an Assistant Professor of Radiology in the Breast Imaging Section at the University of Washington School of Medicine and Seattle Cancer Care Alliance. He is now an attending radiologist at the Virginia Mason Medical Center in Seattle. Dr. Eby has published research on breast MRI, mammography, and image-guided procedures. He is a fellow of the Society of Breast Imaging and a frequent reviewer for both the American Journal of Roentgenology and Radiology.
Dr. Eby is responsible for training residents in clinical breast imaging, including new methods of imaging and interventions. His research interests focus on developing technologies for image-guided treatment of breast cancer.
Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty has reported NO financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Peter R. Eby, MD
The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Sharon Cancino
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Victoria Phoenix, BS
Lisa Schleelein, MEd
Jan Schultz, RN, MSN, CCMEP
Patricia Staples, MSN, NP-C, CCRN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic, Inc., do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME and Hologic, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10
Jointly Sponsored by
This activity is supported by an educational grant from
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.